Carbamic Acid

Carbamic Acid

SCHEMBL18813041

Cc1ccc2cc(-n3nnc4cnc(NC5CCCC5)nc43)ccc2n1.NC(=O)O

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ MAPK6 Q16659 10/20 0.56
▸ GSK3A P49840 3/20 0.52
▸ GSK3B P49841 3/20 0.52
▸ EIF2AK4 Q9P2K8 3/20 0.41
▸ MAPK8 P45983 1/20 0.41
▸ MAPK9 P45984 1/20 0.41
▸ MAPK10 P53779 1/20 0.41
▸ AURKA O14965 3/20 0.39
▸ CDK4 P11802 1/20 0.39
▸ CCND1 P24385 1/20 0.39
▸ CCND2 P30279 1/20 0.39
▸ CCND3 P30281 1/20 0.39
▸ SYK P43405 1/20 0.39
▸ CCNA2 P20248 1/20 0.38
▸ CDK2 P24941 1/20 0.38
▸ CCNA1 P78396 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Carbamic Acid SCHEMBL18813046 0.99 MAPK6 (0.55) MAPK6GSK3AGSK3BEIF2AK4MAPK8
SCHEMBL18830045 0.94 MAPK6 (0.54) MAPK6GSK3AGSK3BEIF2AK4MAPK8
SCHEMBL18830178 0.93 MAPK6 (0.53) MAPK6GSK3AGSK3BEIF2AK4MAPK8
SCHEMBL18813076 0.90 MAPK6 (0.49) MAPK6GSK3AGSK3BEIF2AK4MAPK8
SCHEMBL16012812 0.90 MAPK6 (0.57) MAPK6GSK3AGSK3BEIF2AK4
SCHEMBL16012811 0.90 MAPK6 (0.57) MAPK6GSK3AGSK3BEIF2AK4
SCHEMBL16014366 0.90 MAPK6 (0.57) MAPK6GSK3AGSK3BEIF2AK4
Carbamic Acid SCHEMBL18813174 0.89 MAPK6 (0.56) MAPK6GSK3AGSK3BEIF2AK4MAPK8
Carbamic Acid SCHEMBL18813043 0.89 MAPK6 (0.60) MAPK6GSK3AGSK3BEIF2AK4AURKA
SCHEMBL18813081 0.89 GSK3A (0.55) MAPK6GSK3AGSK3BEIF2AK4MAPK8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2964649-B1 TRIAZOLO[4,5-D]PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF DISEASES SUCH AS CANCER MERCK PATENT GMBH (DE) 2017-05-10 — — EP claimed
Send feedback